AVEO Oncology (Nasdaq: AVEO) announced that its development partner, EUSA Pharma, a specialty pharmaceutical company with a focus on oncology ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE